|
C6ORF182 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.789600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.090500E-02 |
| Normal-vs-Stage2 |
5.524400E-01 |
| Normal-vs-Stage3 |
6.627600E-01 |
| Normal-vs-Stage4 |
9.141600E-01 |
| Stage1-vs-Stage2 |
8.268400E-01 |
| Stage1-vs-Stage3 |
3.697600E-02 |
| Stage1-vs-Stage4 |
1.671980E-01 |
| Stage2-vs-Stage3 |
4.264600E-01 |
| Stage2-vs-Stage4 |
6.061800E-01 |
| Stage3-vs-Stage4 |
6.321000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.857990E-01 |
| Normal-vs-AfricanAmerican |
3.869000E-01 |
| Normal-vs-Asian |
2.600600E-01 |
| Caucasian-vs-AfricanAmerican |
1.247840E-01 |
| Caucasian-vs-Asian |
5.336400E-01 |
| AfricanAmerican-vs-Asian |
2.847000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.197000E-01 |
| Normal-vs-Female |
2.539800E-01 |
| Male-vs-Female |
5.907600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.737000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.379400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.163800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.167600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.851600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.048800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.241600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.610600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.534400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.984400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.131370E-01 |
| Normal-vs-Grade 2 |
4.454400E-02 |
| Normal-vs-Grade 3 |
9.845600E-01 |
| Normal-vs-Grade 4 |
2.848000E-01 |
| Grade 1-vs-Grade 2 |
6.294000E-01 |
| Grade 1-vs-Grade 3 |
7.672000E-02 |
| Grade 1-vs-Grade 4 |
3.416000E-02 |
| Grade 2-vs-Grade 3 |
3.081800E-02 |
| Grade 2-vs-Grade 4 |
7.518400E-03 |
| Grade 3-vs-Grade 4 |
2.567600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.237700E-04 |
| Normal-vs-ccB subtype |
2.273400E-01 |
| ccA subtype-vs-ccB subtype |
4.66820000000201E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.260200E-02 |
| Normal-vs-N1 |
1.932610E-01 |
| N0-vs-N1 |
8.474400E-02 |
|
|
